SL
MRNA icon

Signition LP’s Moderna MRNA Stock Holding History

Signition LP’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,773
Closed -$158K – 137
2019
Q2 		$158K Buy
+10,773
New +$231K 0.1% 156

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
RWA
Ropes Wealth Advisors Boston, Massachusetts $515M AUM 21.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Signition LP's MRNA Position: Q3 2019 in Review

Signition LP sold out of Moderna (MRNA) in Q3 2019, closing a stake of 10,773 shares — an estimated $158K sold.

Signition LP first reported a position in MRNA in Q2 2019 and held it in 1 quarter. The position peaked at $158K in Q2 2019. 136 funds tracked by Wall St. Rank hold MRNA as of Q3 2019.

  • Signition LP reported no remaining Moderna position as of Q3 2019 after selling out during the quarter.
  • Signition LP sold 10,773 Moderna shares in Q3 2019, an estimated $158K.
  • Signition LP first reported a position in Moderna in Q2 2019 and held it in 1 quarter.
  • Signition LP's Moderna position peaked at $158K in Q2 2019.
  • 136 funds tracked by Wall St. Rank held Moderna as of Q3 2019.

Based on Signition LP's 13F filing for Q3 2019, filed 5 Nov 2019.